Avid Bioservices Informs Investors About Changes to Convertible Notes
Avid Bioservices, Inc., a prominent biologics contract development and manufacturing organization, has recently communicated critical updates regarding its 7.00% Convertible Senior Notes due 2029. These announcements relate directly to the company's recent merger activities aimed at enhancing its service offerings to clientele in the biotechnology and pharmaceutical sectors.
Understanding the Fundamental Change Notification
On the condition of executing a merger agreement, a Fundamental Change occurred concerning the convertible notes as of February 5, 2025. This change enables note holders the right to exercise what is termed the "Fundamental Change Repurchase Right." Essentially, this guarantees that holders can request a cash repurchase of their notes, either in total or for an amount that is a multiple of $1,000. The scheduled repurchase date is set for March 12, 2025.
Exercising the Repurchase Right
To enact their repurchase rights, note holders must surrender their notes and adhere to the stipulated rules from The Depository Trust Company by 5:00 p.m. on March 11, 2025. It’s crucial for holders to act promptly if they wish to withdraw any notes that have been surrendered before this deadline, as a timely notice is required to the paying agent, U.S. Bank.
The Make-Whole Fundamental Change Overview
On the same date of February 5, 2025, a Make-Whole Fundamental Change took place, modifying the terms of the notes as per the Indenture directive. This allows holders to convert their notes into cash during a specified time frame referred to as the Make-Whole Fundamental Change Conversion Period. This period lasts until March 10, 2025, and offers an increased conversion rate unique to this timeframe, allowing for a higher cash payout upon conversion.
Details of the Conversion Rate
The adjustment means that upon conversion, each $1,000 principal amount of notes could yield an estimated cash equivalent of approximately $1,422.07. This revised conversion rate is calculated using a new mechanism that factors in additional shares, aimed at benefiting the current note holders in the wake of the Fundamental Change.
Moving Forward After the Change
Investors should be aware that once the Make-Whole Fundamental Change Conversion Period concludes, the conversion terms revert to the original rates used before these recent changes. This means if holders choose not to convert within the specific window, they will miss the opportunity for the increased payout, which could be significant given the adjustments made.
Avid's Commitment to Quality in Biologics Manufacturing
Avid Bioservices is dedicated to providing high-quality contract development and manufacturing services to its clients. With over 30 years of experience, the company aims to enhance patient lives through its meticulous and comprehensive approach to biologics production. This approach encompasses every aspect of manufacturing, from early-stage process development to CGMP clinical and commercial supplies. As the company is navigating through this merger, it continues to prioritize growth and operational excellence, ensuring its clients will receive the best possible services.
Frequently Asked Questions
What is the recent announcement from Avid Bioservices?
Avid Bioservices announced changes regarding its 7.00% Convertible Senior Notes, triggered by a recent merger.
What happens on March 12, 2025?
This date marks the Fundamental Change Repurchase Date, allowing holders to sell their notes back to the company for cash.
What is the Make-Whole Fundamental Change Conversion Period?
It is a specified time frame where note holders can convert their notes into cash at an increased conversion rate.
How much can I expect to receive if I convert my notes?
Holders can expect approximately $1,422.07 for every $1,000 principal amount of notes when converting during the defined period.
What if I miss the conversion period?
If missed, the conversion rights will revert to the previously set rates, losing the benefit of the increased payout.
